Inula nervosa Wall oil capsule preparation and preparation method thereof

A technology of Yunweiling oil and capsules, which is applied in the field of medicine, can solve the problems of many side effects and high cost, achieve good therapeutic effect and ensure the effect of therapeutic effect

Active Publication Date: 2013-10-16
XIANGYU PHARMA
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although these drugs have curative effects, some have many side effects and some are expensive.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0035] The preparation method of described Yunweiling oil capsule preparation is: get above-mentioned weight ratio raw material (proportioning unit is gram) and take immediately

[0036] Yunweiling 80g, Anemarrhena 25g, Guangmuxiang 25g, Curcuma 22g, Myrrh 20g,

[0037] Rehmannia glutinosa 20 grams, Poria cocos 20 grams, acacia peel 18 grams, dandelion 18 grams, dried ginger 17 grams,

[0038] Cistanche 15g, Guizhi 15g, Paeoniae Rubra 13g, Atractylodes 12g, Rhizoma Chuanxiong 12g,

[0039] Nuxychnium 10g, Malt 10g, Chuanwu 10g, Peach Kernel 9g, Licorice 7g,

[0040]7 grams of wang buliuxing, 5 grams of Dipsacus, and 5 grams of frankincense.

[0041] (1) Take 80g of Yunweiling and crush it into 4-8mm particles, add 10 times of water and distill for 6 hours to obtain the distillation extract, separate the oil layer through the oil-water separator, add 10% anhydrous sodium sulfate (weight ratio) for dehydration , filtered to get Yunweiling oil.

[0042] (2) Take 25 grams of A...

Embodiment 2

[0048] 1. Clinical data

[0049] Clinical data: A total of 167 outpatients with complete medical records were selected. Randomly divided into a treatment group of 83 cases, a control group of 84 cases. The age of the treatment group was 29-61 years old, with an average age of 41.7 years; the age of the control group was 30-60 years old, with an average age of 42.3 years. There was no statistically significant difference in age and course of disease (p>0.05) by Chi-square test.

[0050] 2. Diagnostic criteria:

[0051] Diagnostic criteria of western medicine: refer to the diagnostic criteria of rheumatoid arthritis of the American College of Rheumatology in 1989: ①morning stiffness: stiffness in and around the joints lasts for at least 1 hour (duration ≥ 6 weeks); ②joints in 3 or more regional joints Inflammation: Physician observes involvement of 3 out of 14 areas (proximal interphalangeal joints, metacarpal joints, wrist, elbow, knee, ankle, and metatarsophalangeal joints, ...

Embodiment 3

[0060] typical embodiment

[0061] Yuan Mou, male, 59 years old, suffered from rheumatoid arthritis for 10 years, with clinical deformities of wrist, metacarpophalangeal joints or proximal interphalangeal joints. Both wrist joints are red and swollen, painful, fingers are stiff and difficult to flex and stretch, wrist joints are slightly deformed and dislocated, both ankles are painful, the symptoms are mild during the day and worse at night, and the joints are symmetrically swollen and painful. Long-term multiple treatment, effect is not obvious, give embodiment 1 to prepare capsule preparation, pain disappears after a course of treatment, continues to advise and obey a course of treatment, joint deformity disappears, and activity function recovers, everything is normal, follows up a case by regular visits to 1 year without recurrence.

[0062] Duan, female, 41 years old, had mild facial edema, left and right palms swelled significantly, difficulty making fists with both hand...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an Inula nervosa Wall oil capsule preparation, which is prepared from the following raw materials in parts by weight: 80 parts of Inula nervosa Wall, 25 parts of rhizoma anemarrhenae, 25 parts of costus root, 22 parts of curcuma aromatic, 20 parts of myrrh, 20 parts of prepared rehmannia root, 20 parts of tuckahoe, 18 parts of cortex albiziae, 18 parts of dandelion, 17 parts of rhizoma zingiberis, 15 parts of cistanche, 15 parts of cassia twig, 13 parts of root of common peony, 12 parts of rhizoma atractylodis, 12 parts of ligusticum wallichii, 10 parts of nux vomica, 10 parts of malt, 10 parts of radix aconiti preparata, 9 parts of peach kernel, 7 parts of liquorice, 7 parts of the seed of cowherb, 5 parts of teasel root and 5 parts of frankincense. The Inula nervosa Wall oil capsule preparation can treat both symptoms and root causes of rheumatoid arthritis, is harmless and non-toxic for a human body, does not have a side effect, has low price, is simple and convenient to prepare, and has a wide application prospect.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a Yunweiling oil capsule preparation for treating rheumatoid arthritis and a preparation method thereof. Background technique [0002] Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease mainly characterized by joint disease. The main clinical manifestations are joint swelling and pain caused by the synovial membrane of the facet joints, followed by cartilage destruction and joint space narrowing. In the late stage, severe bone destruction and absorption lead to joint stiffness, deformity, and dysfunction. It is a common frequently-occurring disease. Synovial inflammation in the joint cavity, exudate, cell proliferation, granuloma formation, cartilage and bone tissue destruction, and finally joint ankylosis and dysfunction. It mainly affects the joints and the heart, manifested as joint and muscle pain, numbness, swelling, red heat, and autoantibodie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61K9/48A61P19/02A61P29/00
Inventor 林凡儒林凡友
Owner XIANGYU PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap